FDA - China Intellectual Property Lawyers Network

+86-13910160652

+86-10-52852558

EN

CHINA intellectual PROPERTY LAWYERS NETWORK

Chief Lawyer Xu Xinming

Chief Lawyer Xu Xinming

+86-13910160652 ciplawyers@163.com

About Us Consultation

Working Progress

more >

Xu Xinming: Can the Trademark Right of Zhengongfu Beat Bruce Lee’s Portrait Right?
Lasted for Eight Years: Won the Case Concerning the Administrative Dispute over Invalidation of the Invention Patent of Elecon Handled by Lawyer Xu Xinming
IMECAS v. Intel Series Cases of Patent Infringement Disputes
Winning the Case Concerning Dispute over Copyright Transfer Contract of the Musical “Race for Love” Represented by Lawyer Xu Xinming
The Wall Street Journal-Interview-Chief Lawyer Xu Xinming: Delivery Giant Meituan Fined in Beijing’s Tech Crackdown

IP Express

more >

Judicial Development

more >

CASE

more >

IP Theory

more >

IP Practice&View

more >

Determination of "Malice" in Malicious Patent Litigation

Determination of "Malice" in Malicious Patent Litigation

legal System

more >

Chinese Law Library

International Law Library

FDA

US FDA adds 'boxed warning' for Amgen's bone loss drug Prolia

with advanced chronic kidney disease, particularly ones on dialysis, and Prolia. The FDA reviewed 25 cases between July 2010 through May 2021 during the investigation. Boxed warnings are the strictest

Post Time：2024.01.22

1

total 1 pages, 1 items

+86-10-52852558 +86-13910160652